Phunware - PHUN Stock Forecast, Price & News

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Phunware in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" PHUN shares.
View PHUN analyst ratings or view top-rated stocks.

2 equities research analysts have issued 1 year target prices for Phunware's stock. Their PHUN share price forecasts range from $4.00 to $5.50. On average, they expect the company's stock price to reach $4.75 in the next twelve months. This suggests a possible upside of 166.9% from the stock's current price.
View analysts price targets for PHUN or view top-rated stocks among Wall Street analysts.

Phunware's stock was trading at $2.63 at the beginning of the year. Since then, PHUN stock has decreased by 32.3% and is now trading at $1.78.
View the best growth stocks for 2022 here.

Phunware saw a increase in short interest in the month of July. As of July 15th, there was short interest totaling 5,420,000 shares, an increase of 46.9% from the June 30th total of 3,690,000 shares. Based on an average trading volume of 3,010,000 shares, the days-to-cover ratio is currently 1.8 days.
View Phunware's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 11th 2022.
View our PHUN earnings forecast.

Phunware will be holding an earnings conference call on Thursday, August 11th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 919-882-2331 with passcode "46161".

Phunware, Inc. (NASDAQ:PHUN) announced its earnings results on Thursday, November, 11th. The company reported ($0.03) EPS for the quarter, topping analysts' consensus estimates of ($0.04) by $0.01. The company had revenue of $2.16 million for the quarter, compared to analyst estimates of $1.93 million. Phunware had a negative net margin of 346.43% and a negative trailing twelve-month return on equity of 128.71%. During the same quarter in the prior year, the firm posted ($0.10) EPS.

65 employees have rated Phunware Chief Executive Officer Alan S. Knitowski on Glassdoor.com. Alan S. Knitowski has an approval rating of 51% among the company's employees. This puts Alan S. Knitowski in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Phunware investors own include Biocept (BIOC), NIO (NIO), OPKO Health (OPK), Vaxart (VXRT), Outlook Therapeutics (OTLK), Sorrento Therapeutics (SRNE), Advanced Micro Devices (AMD), Bionano Genomics (BNGO), Acasti Pharma (ACST) and Boeing (BA).

Phunware trades on the NASDAQ under the ticker symbol "PHUN."

Phunware's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Independent Wealth Network Inc. (0.03%). Insiders that own company stock include Alan S Knitowski, Eric Manlunas, George Syllantavos, Lori Tauber Marcus and Randall Crowder.
View institutional ownership trends.

Shares of PHUN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of PHUN stock can currently be purchased for approximately $1.78.

Phunware (NASDAQ:PHUN) has a market capitalization of $174.15 million and generates $10.64 million in revenue each year. The company earns $-53,520,000.00 in net income (profit) each year or ($0.67) on an earnings per share basis.

The company employs 120 workers across the globe.

Phunware's mailing address is 7800 SHOAL CREEK BLVD SUITE 230-S, AUSTIN X1, 78757. The official website for the company is www.phunware.com. The company can be reached via phone at (512) 693-4199 or via email at investorrelations@phunware.com.